Reduction Engineering Scheer, a leading global manufacturer of strand pelletising systems, has introduced a new line of pharmaceutical-grade strand pelletisers that are used when pharmaceutical drugs are mixed with active ingredients in an extruder.
Reduction Engineering sees increased demand from the pharmaceutical industry for these pelletiser systems and has entered the market.
The pharmaceutical-grade pelletisers are for applications that must comply with strict regulations in terms of construction materials, cleanability and documentation, according to John Sly, Sales Manager for Reduction Engineering. ‘Our speciality pelletisers deliver high performance and meet the stringent demands of the pharmaceutical industry,’ he said.
Pelletisers for these compounding processes are carefully designed and micropolished to eliminate hang-up points, which reduces the potential for contamination. The stainless steel system is polished to a specific finish for a complete, meticulous clean.
The pharmaceutical-grade pelletisers are similar in design and construction to Reduction Engineering’s SGS 25 E4 and Bullet Series line, which is known for its user friendliness, fast turnarounds and high efficiency. They are available in four sizes with 1-, 2-, 4- and 6-in cutting widths. They are commercially available and have been sold to both OEMs and compounders in the US.
